Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial

Type 2 diabetes mellitus (T2DM) is associated with premature atherosclerosis and arterial stiffening due to the accumulation of advanced glycation end-products in vessel walls. Green tea polyphenols are considered cardio-protective substances. In this randomised double-blind placebo-controlled trial...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of food sciences and nutrition Vol. 70; no. 8; pp. 977 - 985
Main Authors Quezada-Fernández, Patricia, Trujillo-Quiros, Jhonatan, Pascoe-González, Sara, Trujillo-Rangel, Walter A., Cardona-Müller, David, Ramos-Becerra, Carlos G., Barocio-Pantoja, Maricruz, Rodríguez-de la Cerda, Mariana, Nérida Sánchez-Rodríguez, Esther, Cardona-Muñóz, Ernesto G., García-Benavides, Leonel, Grover-Páez, Fernando
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 17.11.2019
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Type 2 diabetes mellitus (T2DM) is associated with premature atherosclerosis and arterial stiffening due to the accumulation of advanced glycation end-products in vessel walls. Green tea polyphenols are considered cardio-protective substances. In this randomised double-blind placebo-controlled trial (NCT02627898), we evaluated the effect of Green tea extract on arterial stiffness parameters, lipids, body composition and sRAGE levels. Twenty normotensive patients with T2DM treated with the standard therapy and statins, mean age 53.2 ± 9.4 years and mean BMI 30.1 ± 4.5 kg/m 2 , were randomised to receive a daily dose of 400 mg of green tea extract (polyphenols ≥90%, EGCG ≥45%) or placebo for 12 weeks. Compared to placebo, administration of green tea extract decreased central augmentation index (-3.05 ± 10.8% vs. 6.7 ± 0.1%, p = .04). These findings suggest that green tea extract could be used as an adjunct to the standard therapy to improve arterial stiffness in T2DM.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0963-7486
1465-3478
DOI:10.1080/09637486.2019.1589430